Global Cancer Immunomodulators Pipeline Market

Report ID : 1074 | Published : 2021-07-23 | Pages: 140 | Format: PDF/EXCEL

Prevention of progression and proliferation of infectious diseases in the body has always been the point of discussion, which has developed a throng of techniques to alter these effects of the immune system. Immunotherapy is a treatment that uses particular parts of a person’s immune organism to fight against cancer. The immune system is a collection of special cells, organs and substances which protect us from diseases and infections. Immune cells and the substances that make set out through your body to shield it from germs that cause diseases. The immune system monitors the majority of the substances typically found in the body. Immunomodulators have the ability to augment or reduce immune reactions depending upon the nature of the ailment.
Investigators are successful in identifying the clinical application of these immunomodulators. Immunomodulators in the body undergo biochemical and biophysical changes and auto-trigger to target their own components like that happens in autoimmune disorders. To imply this effect on cancerous cells has gained much focus. Cancer immunotherapy is a medicine that outfits and upgrades the inborn forces of the immune system to battle tumor which represents the most promising new disease treatment approach since the improvement of the principal chemotherapies. Expansion of bioinformatics tools that enhance drug development procedure, growth in adoption of immunotherapy above other treatment alternatives and increase in incidence rate of cancer worldwide have made it the most focusing arena.
Many molecules are being studied for their oncological application, may have been introduced into the market while many are under development which are expected to increase in number in coming years. Due to high unmet medical demand and market potential, pharmaceutical companies have made huge investments in research and development.
These immunomodulators in cancer have been segmented based on application, mechanism, route of administration, and phase.
Based on application, the global cancer immunotherapy market is segmented into breast cancer, prostate cancer, melanoma, colorectal cancer, head & neck cancer, lung cancer, and others (cervical, renal cell carcinoma, gastric, lymphoma). The lung cancer segment is expected to witness the highest CAGR, owing to the increased incidence of this type of cancer. All the 700 plus drugs under pipeline and 300 marketed drugs are reviewed. Identifying drugs that are linked to various targets like ATPase, b cell receptor, carboxy-lyase activity, cell adhesion molecule activity, cytokine activity, DNA topoisomerase activity, g-protein coupled receptor activity, growth factor activity, heat shock protein activity, MHC class receptor activity, protein binding, RNA binding, voltage-gated ion channel activity and other that include almost 500 targets divided into various classifications that are administered via different routes of administration.
Some of the molecules under development include GC5107B(Green Cross) in Phase 3, CSL 312 (CSL Behring) in Phase 2, GNR-045 (Generium) and TOT401 (TTY Biopharm) in preclinical stage of development. Some products like ImmunoRel of Reliance Life Sciences, Albuminar of CSL, Cerebrolysin of Novartis are already in the market.
Some of the key players include 3M Pharmaceuticals, AbGenomics Corporation, Advaxis ,Amgen , ANI Pharmaceuticals, Argos Therapeutics, AVAX Technologies , Baxte International, Biosidus , Biovest International , BMS, Celgene, Curadev, GSK, Gradalis, Incyte, Intas, iTeos Biopharma, Kyorin Pharma, Merck, Northwest Biotherapeutics, Novartis, Pfizer, Roche, Sanofi

  • 3M Pharmaceuticals
  • AbGenomics Corporation
  • Advaxis
  • Amgen
  • ANI Pharmaceuticals
  • Argos Therapeutics
  • AVAX Technologies
  • Baxter International
  • Biosidus
  • Celgene
  • Novartis
  • Pfizer
  • Roche
  • Sanofi
  • Other Prominent Player with Pipeline Product Portfolio

Global Cancer Immunomodulator PIpeline Market Outlook (Revenue, US$ Mn, 2019 – 2030)

  • Market Overview
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Major Qualitative Insights

  • Industry Overview
  • Key market trends
  • Market Drivers and Challenges
  • Market Size and Forecast
  • Clinical Trial/Pipeline Analysis
  • Key News/Industry Activities
  • Major Mergers & Acquisition
  • Competitive Landscape
  • Company Overview
  • Financial Performance
  • Key Development
  • Latest Strategic Developments

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients